Somerset TherapeuticsdrugHigh PriorityActive

Cisatracurium Besylate Recall

Cisatracurium Besylate Injection 20 mg/10 mL* has been recalled due to subpotent product:out of specification assay results observed during long term stability testing.. This recall primarily affects healthcare facilities, hospitals, and pharmacies. Individual consumers are unlikely to have this product at home. Check the official FDA notice for specific lot numbers and return or disposal instructions.

By RecallRadar Editorial Team

Sourced from FDA. Last verified March 4, 2026.

On this page

Free checker

Check if you qualify

See whether your device may qualify for a free repair or replacement program before you spend money.

Check if you qualify

Key facts

Date announced: November 26, 2025
Source agency: FDA

This recall involves safety concerns. Take action promptly.

✨ Plain-English Summary

Is This Recall Still Active?

Status: Yes - Active

This recall is currently active. If your device matches the affected models, follow the official instructions as soon as possible.

What's Being Recalled

Quoted source excerpt from the official notice.

Subpotent product:out of specification assay results observed during long term stability testing.

Quick Info

Key facts from the official notice, kept in the article flow for easy cross-checking.

Brand: Somerset therapeutics
Category: drug
Source agency: FDA
Announced: November 26, 2025
Country: US
Status: Active

Who's Affected

Specific models and identifiers listed in the source notice:

Model #1

Lot#: A250043, EXP Date 06/30/2026

#	Model
1	Lot#: A250043, EXP Date 06/30/2026

Technical model codes are manufacturer identifiers. Match both the product name and model code from your device settings, label, or packaging.

What You Should Do

Follow the remedy path from the official notice using the exact model and serial details above.

1## Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, 10mL Multiple-dose vial, NDC 70069-161-01; 10x10mL Multiple Agency: FDA | Category: drug Reason: Subpotent product:out of specification assay results observed during long term stability testing. What to do:
2Stop using the product if your lot/model matches.
3Check the FDA notice for specifics.
4Follow remedy instructions.

Open Official Recall Notice

Source & Verification

This page summarizes the official notice and keeps key facts easy to verify.

Official source: FDA
Announced by source: November 26, 2025
Last reviewed by RecallRadar: March 4, 2026

Frequently Asked Questions

Am I affected by this recall?

Check the affected models section on this page. The official notice currently lists Lot#: A250043, EXP Date 06/30/2026.

What is the remedy for this recall?

## Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, 10mL Multiple-dose vial, NDC 70069-161-01; 10x10mL Multiple Agency: FDA | Category: drug Reason: Subpotent product:out of specification assay results observed during long term stability testing. What to do: 1. Stop using the product if your lot/model matches. 2. Check the FDA notice for specifics. 3. Follow remedy instructions.

Where can I verify recall details?

Use the official source link in this page to confirm dates, eligibility, and next steps: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Keep browsing with these internal hubs: Somerset Therapeutics recall hub and Food & Drug recall hub.